Kilitch Drugs to Sell Ethiopian Subsidiary Stake for $14 Million
Kilitch Drugs said it is divesting its entire shareholding in Kilitch Estro Biotech PLC to Ethiopian state-owned HarmeeCare Pharmaceuticals for $14 million.
Kilitch Drugs (India) Ltd said it was divesting its entire shareholding in its Ethiopian subsidiary, Kilitch Estro Biotech PLC (KEB) to HarmeeCare Pharmaceuticals, an Ethiopian State-owned enterprise, for $14 million.The proposed transaction is part of the company’s strategy to optimise its portfol…